Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal Donors

KRN125 for Mobilization of Hematopoietic Stem Cells

NCT03993639 ·Status: COMPLETED ·Phase: PHASE2

Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy

NCT00035594 ·Status: COMPLETED ·Phase: PHASE3

PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy

NCT02805153 ·Status: COMPLETED ·Phase: PHASE4

Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy

NCT00035620 ·Status: COMPLETED ·Phase: PHASE2

Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer

NCT01724866 ·Status: COMPLETED ·Phase: PHASE2

A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy

NCT01285219 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203)

NCT03011372 ·Status: COMPLETED ·Phase: PHASE2

Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)

NCT00114764 ·Status: COMPLETED ·Phase: PHASE2

Treatment for Elderly Patients With High Risk Breast Cancer

NCT00117910 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Dose-response, Pharmacodynamic and Pharmacokinetic Bioequivalence of Filgrastim in Healthy Male Volunteers After Single and Multiple-dose Subcutaneous Administration of the Test Injectable Formulation BK0023 vs. Neupogen®

NCT01933971 ·Status: COMPLETED ·Phase: PHASE1

PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia

NCT02805205 ·Status: COMPLETED ·Phase: PHASE4

SubCutaneous (SC) Versus Intravenous (IV) Granulocyte Colony Stimulating Factors (G-CSF) for the Treatment of Neutropenia in Hospitalized Haemato-oncological Patients

NCT01222819 ·Status: TERMINATED ·Phase: PHASE4

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

NCT01459653 ·Status: COMPLETED

Biosimilarity Study of Subcutaneous Pegfilgrastim in Healthy Volunteers

NCT04873765 ·Status: COMPLETED ·Phase: PHASE1

FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy

NCT00125723 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of Biosimilar Filgrastim on the Mobilization of Hematopoietic Stem Cell CD34+ (Cluster of Differentiation 34) and on the Kinetic Engraftment

NCT02806791 ·Status: UNKNOWN

Safety and Efficacy of TXA127 and Neupogen to Increase Peripheral Blood Stem Cells (PBSCs)

NCT01543971 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy

NCT06711523 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy

NCT00111462 ·Status: COMPLETED ·Phase: PHASE2

Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel

NCT00837265 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Comparative, Crossover, Pharmacokinetic, Pharmacodynamic and Safety Study of Three Forms of PEG-G-CSF in Normal Healthy Volunteers

NCT02205320 ·Status: UNKNOWN ·Phase: PHASE1

Nanogen Pegfilgrastim (Pegcyte) PK/PD Clinical Study in Breast Cancer Patients

NCT03376503 ·Status: COMPLETED ·Phase: PHASE1

Comparison of Quality and Quantity of M-PRP Cellular Content Filgrastim vs. Pegfilgrastim

NCT05573386 ·Status: COMPLETED

Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia

NCT01918241 ·Status: UNKNOWN ·Phase: PHASE2

Biosimilarity Study of Subcutaneous Filgrastim in Healthy Volunteers

NCT04958772 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1